Radiopharmaceuticals Market Research Reports & Consulting

discount on Mnm

Market Reports

Title Published Price TOC Available

Nuclear Medicine/ Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023

The nuclear medicine/ radiopharmaceuticals market is projected to reach $5.26 billion by 2023 from an estimated $3.95 billion in 2018 at a CAGR of 5.9%. The major influencing factors driving the growth of this market are the increasing incidence and prevalence of target conditions and initiatives to lessen the demand-supply gap of Mo-99. Cardinal Health (US), GE Healthcare (US), and Curium (France) are the key players in the nuclear medicine. Other players involved in this market are Bayer (Germany), Lantheus Medical Imaging (US), Advanced Accelerator Applications (France), and Jubilant Life Sciences (India).

June 2018 $ 5650 selected

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 

Live Chat Support

US : 1-888-600-6441
UK : 44-800-368-9399

Search reports

M&M Custom Research Services provides clients with the information on their business scenario required to stay ahead of competition in today's fast paced business environment.
'Connect With Us

Call us at: 1-888-600-6441
Live Chat Support

Access reports on all high
growth Radiopharmaceuticals Markets on KnowledgeStore
Request Demo